A team of researchers from Sunnybrook Research Institute and Lawson Health Research Institute is leading a multi-centre trial investigating whether inhaled sedatives can replace those typically delivered intravenously for COVID-19 patients requiring ventilation.
The purpose of the study, co-led by Dr. Angela Jerath (pictured), is to evaluate whether inhaled volatile sedation can be used effectively in ventilated COVID-19 patients, thereby easing pressure on IV sedation stocks. The study is also evaluating if patients recover faster with this form of sedation.